Novel 3D cytotoxicity assay to assess the impact of chimeric antigen receptor (CAR) domain design on the tumor infiltration and cytotoxicity efficacy of CAR T-cell therapies for solid tumors

被引:0
|
作者
Johnston, Adrian
Wan, Zeqi
Chen, Tina
Lim, Yeongseo
Lee, Cameron
Du, Wenxuan
Philip, Jude
Wirtz, Denis
机构
关键词
D O I
10.1158/1538-7445.AM2023-4710
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4710
引用
收藏
页数:2
相关论文
共 32 条
  • [1] Effect of dendritic cells (DC) transduced with chimeric antigen receptor (CAR) on CAR T-cell cytotoxicity
    Suh, Hyung Chan
    Pohl, Katherine
    Javier, Anna Patricia L.
    Slamon, Dennis J.
    Chute, John P.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [2] Advances in Chimeric Antigen Receptor (CAR) T-Cell Therapies for the Treatment of Primary Brain Tumors
    Mount, Christopher W.
    Gonzalez Castro, Luis Nicolas
    ANTIBODIES, 2022, 11 (02)
  • [3] Tumor retargeting universal chimeric antigen receptor T cell (TRUE-CAR T) therapy in solid tumors
    Meng, F.
    Sun, Z.
    Liu, B.
    ANNALS OF ONCOLOGY, 2022, 33 : S10 - S11
  • [4] Critical factors in chimeric antigen receptor-modified T-cell (CAR-T) therapy for solid tumors
    Yan, Lingli
    Liu, Bainan
    ONCOTARGETS AND THERAPY, 2019, 12 : 193 - 204
  • [5] A novel multicolor fluorescent spot assay for the functional assessment of chimeric antigen receptor (CAR) T-cell products
    Atanackovic, Djordje
    Iraguha, Thierry
    Omili, Destiny
    Avila, Stephanie V.
    Fan, Xiaoxuan
    Kocoglu, Mehmet
    Gebru, Etse
    Baker, Jillian M.
    Dishanthan, Nishanthini
    Dietze, Kenneth A.
    Oluwafemi, Ayooluwakiitan
    Hardy, Nancy M.
    Yared, Jean A.
    Hankey, Kim
    Dahiya, Saurabh
    Rapoport, Aaron P.
    Luetkens, Tim
    CYTOTHERAPY, 2024, 26 (04) : 318 - 324
  • [6] 3D hanging spheroid plate for high-throughput CAR T cell cytotoxicity assay
    Zhenzhong Chen
    Seokgyu Han
    Arleen Sanny
    Dorothy Leung-Kwan Chan
    Danny van Noort
    Wanyoung Lim
    Andy Hee-Meng Tan
    Sungsu Park
    Journal of Nanobiotechnology, 20
  • [7] Three-dimensional cytotoxicity assay using magnetic 3D bioprinting for measuring CAR T cell function in heterogeneous solid tumor microenvironments
    Souza, Glauco R.
    Najjar, Amer
    CANCER RESEARCH, 2019, 79 (13)
  • [8] Clinical Impact of Bridging Therapy Prior to Commercial Chimeric Antigen Receptor (CAR) T-Cell Therapies for Relapsed/Refractory Lymphomas
    Imber, Brandon S.
    Perales, Miguel-Angel
    Flynn, Jessica
    Ruiz, Josel D.
    Devlin, Sean
    Tomas, Ana Alarcon
    Hajj, Carla
    Batlevi, Connie Lee
    Dahi, Parastoo B.
    Lin, Richard J.
    Park, Jae H.
    Scordo, Michael
    Shah, Gunjan L.
    Giralt, Sergio A.
    Sauter, Craig S.
    Palomba, M. Lia
    Yahalom, Joachim
    BLOOD, 2020, 136
  • [9] NKG2D/CD28 chimeric receptor boosts cytotoxicity and durability of CAR-T cells for solid and hematological tumors
    Teng, Xia
    Li, Shance
    Zhang, Chaoting
    Ding, Huirong
    Tian, Zhihua
    Zhu, Yuge
    Liu, Ting
    Zhang, Guanyu
    Sun, Kang
    Xie, Huimin
    Tu, Jiaxin
    Lu, Zheming
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2025, 14 (01)
  • [10] Evaluation of CAR-T cytotoxicity in solid tumors: A screening workflow using 3D patient-derived tumoroids
    Yang, Xiaoyu
    Mafreshi, Maryam
    Wong, Garrett
    Chandra, Vivek
    Paul, Colin
    Yankaskas, Chris
    Balhouse, Brittany
    Sharp, Jason
    Dallas, Matt
    Willems, Erik
    Kuninger, David
    CANCER RESEARCH, 2024, 84 (06)